Advertisement BMS signs antibiotics sales deal with Ventiv Pharma - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BMS signs antibiotics sales deal with Ventiv Pharma

Ventiv Pharma Services, a division of Ventiv Health Inc, has signed a multi-year service agreement with Bristol-Myers Squibb for a sales force of over 375 representatives focused on antibiotics Cefzil and Tequin.

Under the terms of the agreement, Ventiv Pharma Services will provide Bristol-Myers Squibb with a professional sales representative team, the entire field and internal management staff, full operational support to include sales force automation, help desk support and analysis and reporting services.

“We are delighted to announce that one of our previously-announced significant new contracts is with Bristol-Myers Squibb,” said Terrell Herring, president and COO of Ventiv Pharma Services. “Even more so, we are pleased with the confidence shown in our organization.”

Ventiv Health Inc provides late-stage clinical, sales, marketing and compliance solutions to the world’s largest pharmaceutical companies as well as to emerging and specialty pharmaceutical and biotech organizations. Ventiv’s clients include more than 75 pharmaceutical and biotech organizations, including virtually all of the top 20 global pharmaceutical companies.